Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Recruiting · NCT05266417 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease | Insulin Resistance, Nutritional and Metabolic Diseases, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-07-22 | NCT05266417 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gateway Institute for Brain Research | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charter Research | The Villages | United States | 8 |
| Institute for Neuroimmune Medicine | Davie | United States | 1 |
| Las Mercedes Medical Research | Hialeah | United States | 5 |
| NextGen Research Group | Miami | United States | 1 |